Abstract Details
|
Jaime Hatcher-Martin, MD, PhD, FAAN
(Synapticure)
PRESENTER |
Dr. Hatcher-Martin has received personal compensation for serving as an employee of Synapticure. Dr. Hatcher-Martin has received personal compensation for serving as an employee of HD Genetics. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Science37. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npc Parkinson's Disease Journal. |
| Eric Anderson, MD, PhD, FAAN (Intensive Neuro) | Dr. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sindler Law firm, WVU, MayerLLP, KBA attorneys. Dr. Anderson has or had stock in Synapticure. The institution of Dr. Anderson has received research support from NIH. |
| Stewart A. Factor, DO, FAAN (Emory University School of Medicine) | Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. |